Facebook
Twitter
Telegram
Report an ErrorZentalis Pharmaceuticals Cash Flow 2011-2024 | ZNTL
Annual Cash Flow Zentalis Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-208 M | -164 M | -154 M | -86.8 M | -39.1 M | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
1.39 M | 1.43 M | 544 K | 160 K | 111 K | - | - | - | - | - | - | - | - |
Accounts Payables |
14.9 M | 11.2 M | 11.6 M | 8.66 M | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
3.34 M | 508 K | 258 K | 417 K | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Zentalis Pharmaceuticals
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-52 M | - | - | - | -49.3 M | - | -126 M | -93.2 M | -50.2 M | - | -117 M | -83.6 M | -37.5 M | - | -59.5 M | -38.9 M | -16.9 M | - | -26 M | -16 M | -9.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
324 K | - | 348 K | 344 K | 360 K | - | 375 K | 348 K | 344 K | - | 137 K | 119 K | 79 K | - | 51 K | 38 K | 38 K | - | 25 K | 24 K | 21 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
10.5 M | 14.9 M | 14.3 M | 12.3 M | 12.8 M | 11.2 M | 9.82 M | 12 M | 13.2 M | 11.6 M | 8.05 M | 8.27 M | 8.34 M | 8.66 M | 8.66 M | 8.66 M | 8.66 M | 4.29 M | 4.29 M | 4.29 M | 4.29 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
3.16 M | 3.34 M | 1.93 M | 878 K | 385 K | 508 K | 417 K | 465 K | 266 K | 258 K | 108 K | 5 K | 248 K | 417 K | 417 K | 417 K | 417 K | 140 K | 140 K | 140 K | 140 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency